Ladies and Gentlemen, Dear colleagues and partners,
I am pleased to inaugurate the website dedicated to “PYRAPREG Project”. This platform offers an opportunity for regular exchange on the implementation status of this challenging but exciting project, share experiences and best practices as well as innovative ideas for our future development.
Once again, on your behalf, I would like to sincerely thank our partners for both financial and technical supports and their commitment to this noble cause i.e. combatting malaria in general and in pregnant women in particular. I am convinced and hoped that working closely together, we will add our value to the management of malaria in African pregnant women.
I look forward to seeing your posts, news and suggestions for the improvement of this website.
As part of the clinical trial preparations, the clinical teams of the five different trial sites were trained in essential aspects of the study. During 10-18 February 2020 a training
7 million for testing new anti-malaria drug in pregnant women In five African countries, a large study of a new malaria drug will soon start among pregnant women. EUR 7